Genomic Applications Partnership Program (GAPP) Archives

A National prospective epitope-compatibility matching program for Cana...

Chronic kidney disease (CKD) is a major global health issue and a leading cause of death. For many patients, kidney transplantation is the best available treatment, offering longer...

February 16, 2026

Human Health

RapidOmics 2.0: Long-read Genome Sequencing for Urgent Genetic Disease...

Genetic disorders are a leading cause of major illness and death in infancy. Although precise diagnosis is necessary, access to genome‐wide sequencing is limited in British Colum...

August 30, 2024

Human Health

Parent–of–Origin–Aware genomic analysis...

Around 300,000 unidentified Canadians are at high risk for developing hereditary cancers. This is a missed opportunity for preventing or catching cancer early. Although current gen...

June 27, 2024

Human Health

Surveillance Alert for Fast Epidemiology Genomics and Unified Agile Re...

The current public health approach to monitoring pathogen infections in the population is through testing of all symptomatic individuals. This approach is expensive to implement on...

January 03, 2024

Fisheries and Aquaculture

Complex Gill Disease Initiative (CGDI)...

Salmon production in Canada is under increasing threat from infectious and non-infectious diseases. Over the last decade, gill health and associated diseases ha...

January 12, 2022

Agrifood

CLEan plAnt extractioN SEquencing Diagnostics (CLEANSED) for Clean Gra...

Grapevine virus disease management has been identified by the grape grower and wine industries as a top priority for long‐term sector sustainability. Losses of over $23 mil...

October 07, 2021

Agrifood

Fast-Track Breeding of Powdery-Mildew Resistant Cannabis...

Following the legalization of cannabis in Canada in 2018, the industry quickly grew into a billion-dollar sector. However, decades of prohibition left cannabis behind other major c...

May 25, 2021

Human Health

Implementation of Diagnostic Whole Genome Sequencing for Rare Diseases...

In the province of British Columbia, each year thousands of patients with genetic disorders require access to complex genetic tests that currently must be performed in laboratories...

May 25, 2021

Human Health

Integrating Pediatric Pharmacogenomic Testing into the Canadian Health...

Pharmacogenomics is the study of how an individual’s genes affect their ability to respond to medications (drugs). This project has developed and implemented pharmacogenomic ...

May 25, 2021

Data and Technology Human Health

iMALDI-based Assays for Protein Activity to Improve Patient Selection ...

Research is discovering that cancer is not the monolithic disease it was once thought to be. In fact, most cancer types have many sub-types, each with its own distin...

May 25, 2021

Human Health

Antibody Therapeutics for Duchenne Muscular Dystrophy...

Duchenne Muscular Dystrophy (DMD) is the most prevalent genetic disorder in the world, affecting 1 in 3500 males in Canada. People with DMD have a mutation in a gene that makes dys...

May 25, 2021

Forestry

Cedar Enhanced Durability and Resistance (CEDaR): Sustainability of Ca...

Canada’s $1.1B iconic western redcedar (WRC) export industry is facing a precipitous decline, as the durable and aesthetically appealing timber supply moves from old growth t...

May 25, 2021

Forestry

Protecting Canada’s Forests against Invasive Alien Species by Ne...

In 2016, the forest industry contributed over $23 billion to Canada’s nominal Gross Domestic Product. As one of the most important manufacturing sectors, forestry made ...

May 25, 2021

Data and Technology Human Health

Development of Disease Biomarker Assessment Assays and Kits for Target...

Protein biomarker research has been limited by the lack of available tools to perform rapid and robust quantitation, especially in small sample volumes. Existing technologies ...

May 25, 2021